Anxo Pharmaceutical Co., Ltd. (TPEX: 6677)
Health Care · Pharmaceuticals · TW
NT$16.50
+0.30% today · -29.9% 1Y
Anxo Pharmaceutical Co., Ltd. (TPEX: 6677) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $28.95M and employs 15 people.
Over the last twelve months the share price has lost 29.9%, trading between 15.50 and 30.50.
Tweenvest scores Anxo Pharmaceutical Co., Ltd. across four factors: quality 61/100, value 75/100, growth 15/100. Its strongest factor is value.
6677 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $28.95M
- Revenue (TTM)
- $27.62M
- P/E
- —
- EPS
- -0.37
- Dividend yield
- —
- Beta (5Y)
- 0.30
- 52-week high
- NT$30.50
- 52-week low
- NT$15.50
- Avg volume (3M)
- —
- Shares outstanding
- 55.87M
- Employees
- 15
- Next earnings
- —
About Anxo Pharmaceutical Co., Ltd.
Anxo Pharmaceutical Co., Ltd. functions as a specialized enterprise in the pharmaceutical sector. This company is actively involved in the research, production, and global distribution of various medicinal products, catering to both healthcare professionals and individual patients, particularly within Taiwan and across international markets. Its comprehensive product catalog features both prescription-only drugs and over-the-counter remedies, addressing a broad spectrum of therapeutic needs. These include cardiovascular health, metabolic disorders, conditions affecting the central nervous system, diabetes management, respiratory ailments, anti-infective treatments, dermatological issues, nephrology, urology, and orthopedics, among others. More specifically, Anxo supplies agents for antidiabetic and dyslipidemic conditions, supports cardiovascular and circulatory systems, offers therapies for the nervous system, addresses hepatological and gastroenterological concerns, provides anti-infective and antiviral agents, and assists with hemodialysis and urinary system treatments. Additionally, their offerings cover respiratory system and antihistamine applications, various analgesics, and other specialized medications, including a range of injectable pharmaceuticals. Established in 2003, the company's main operational base is situated in Taipei, Taiwan.
- ISIN
- TW0006677008
- Founded
- 2003
- Listed since
- Jun 27, 2018
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.